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Abstract
Background: Breast cancer is a major malignancy affecting females worldwide. It is the most
common cause of death from cancer in women. Cell lines are widely used in laboratory research
and particularly as in vitro models in cancer research. But we found that the routinely used breast
cancer cell lines were mostly derived from Caucasians or African-Americans. There were few
standard models to study the pathogenic mechanism at molecular level and cell signaling pathway
of breast cancer for Asian patients. It is quite necessary to establish new breast cancer cell lines
from xanthoderm to study the pathogenic mechanism and therapeutic methods.
Results:  Three new breast cancer cell lines, designated BC-019, BC-020 and BC-021, were
successfully established and characterized from breast invasive ductal carcinoma tissues of three
Chinese female patients. These new cell lines growing as adherent monolayer with characteristic
epithelial morphology could be maintained continuously in vitro, and they were ER-, PR- and C-
erbB-2-positive. Their chromosomes showed high hyperdiploidy and complex rearrangements, and
they displayed aggressive tumorigencity in tumorigenesis test.
Conclusion: The three newly established breast cancer cell lines from Chinese patients were
tested for a number of, and the results indicate that the cell lines were in good quality and could
be served as new cell models in breast cancer study.
Background
Breast cancer is a major malignancy affecting females
worldwide. It is the most common cause of death from
cancer in women [1-3]. Cell lines are widely used in labo-
ratory research and particularly as in vitro models in cancer
research. Apart from MCF-7, the most commonly used
breast cancer cell line in the world derived from a pleural
effusion in the Michigan Cancer Foundation [4], a
number of other cell lines are routinely used as breast can-
cer models, such as BT20, MDA-MB-231, MDA-MB-435s,
and T-47D [5]. Moreover, most in vitro studies using
breast cancer cells are based on a few well-characterized
cell lines, such as MCF-7, ZR-75-30, T-47D and MDA-MB-
231, which have been established in culture for over 30
years[4,6,7]. Furthermore, most of these long established
breast cancer cell lines are not derived from primary breast
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tumors, but from tumor metastases, especially aspirates or
pleural effusions.
We also found that these routinely used breast cancer cell
lines were mostly derived from Caucasians or African-
Americans, such as MCF-7, ZR-75-30, T-47D and MDA-
MB-468, but very rarely cell lines were derived from xan-
thoderm, particularly from Asians. In American Type Cul-
ture Collection (ATCC), there were more than 70 breast
cancer cell lines, but only one of them was derived from
Asian(Hs 739.T, ATCC NO.: CRL-7477) and one from
East Indian (HCC1954, ATCC NO.: CRL-2338). And there
were few standard models to study the pathogenic mech-
anism at molecular level and cell signaling pathway of
breast cancer for Asian patients. Even in some studies on
tumor pathologic features in Chinese patients, only the
cell lines derived from Caucasians or African-Americans
were used, so there were few experimental systems to
study the pathogenic mechanism of breast cancer for
Asian patients [8]. In our previous work about the breast
cancer associated gene BRCA1, we also used the cell lines
ZR-75-30 and MDA-MB-435S as investigate objects[9]. In
China, the incidence rate of breast cancer has been seen
increasing significantly both in urban and rural areas in
the last three decades[10,11]. So it is quite necessary to
establish new breast cancer cell lines from xanthoderm to
study the pathogenic mechanism and therapeutic meth-
ods.
In this report, we established and characterized three new
breast cancer cell lines BC-019, BC-020 and BC-021 from
three Chinese patients. These cell lines which are positive
for estrogen receptor (ER), progesterone receptor (PR) and
C-erbB-2, could provide us with new experimental mate-
rials to study the pathogenic mechanism and to screen for
new therapeutic reagents against breast cancer.
Methods
Primary Culture and Establishment of Cell Lines
Three breast cancer cell lines were established from three
Chinese female breast cancer patients who underwent
mammary gland excision in Zhongnan Hospital of
Wuhan University. The study was approved by the hospi-
tal ethics committee and patient's informed consent was
obtained. The tumor specimen from primary mammary
glands was removed at the excision operation. Standard
blocks were then taken for pathological examination
(Table 1). Tissue samples were processed for primary cul-
ture as described previously [12]. Briefly, tumor specimen
was washed five times in Hanks' balanced saline and
minced with scissors into small pieces of 1–3 mm3. The
small tissue fragments were placed in three 25-cm2 culture
flasks and cultured at 37°C in a humidified incubator
containing 5% carbon dioxide in Eagle's minimum essen-
tial medium (MEM) with non-essential amino acids sup-
plemented with 10% fetal bovine serum (FBS,
Invitrogen), penicillin (100 U/mL), and streptomycin
(100 μg/mL). Half of the medium was replaced every 3–4
days. Sparsely outgrowth colonies of polygonal epithelial
cells from the tissue pieces were observed within 5 days.
On the 12th day after initiation of the primary culture, the
epithelial cells were transferred selectively to fresh culture
flasks. Cells were harvested after treatment with 0.25%
trypsin and 0.02% EDTA solution and subcultured with a
1:3 split ratio. During the subsequent period of continu-
ous propagation by subculture, the cells were sampled at
intervals, resuspended in a freezing medium (80% MEM,
10% FBS, and 10% dimethyl sulfoxide [DMSO]), and
stored in liquid nitrogen every ten passages. After quickly
thawing at 37°C, the frozen cells could be propagated in
culture without noticeable change in growth and mor-
phology. The cell lines were named BC (breast cancer)-
019, BC-020, BC-021 and deposited in China Center for
Type Culture Collection (CCTCC) with designation
number CCTCC-GDC0198, CCTCC-GDC0199 and
CCTCC-GDC0200, respectively.
Assay of Growth Characteristics of Cell Line
BC-019, BC-020 and BC-021 cells at the same passage 21
(P21) were used to plot the growth curve by using the 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT) method [13-16]. The cells were plated into 96
well plates, 2 × 103 cells per well and 7 plates per cell line.
One plate of each cell line was assayed every 24 hours. The
absorbance was measured in a microtiter plate reader at
570 nm as the test wavelength and 690 nm as the refer-
ence wavelength. The number of cells was calculated by
the result of MTT compared with the cell number at the
first day. The growth curves were plotted and the popula-
tion doubling time of these 3 cell lines were calculated
during the exponential growth phase of the cells.
Table 1: Origins of the three breast cancer cell lines
Cell line Species Gender Age Source Pathology
BC-019 Human, Chinese Female 47 Right breast Invasive ductal carcinoma
BC-020 Human, Chinese Female 50 Left breast Invasive ductal carcinoma
BC-021 Human, Chinese Female 42 Left breast Invasive ductal carcinomaCancer Cell International 2009, 9:2 http://www.cancerci.com/content/9/1/2
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Contamination Tests
Testing for Bacteria and Fungi
Detection of the contaminants in cell lines followed the
standard procedures of American Type Culture Collection
(ATCC)[17]. The cells at passage 21 (P21) were cultured
with the above-mentioned medium without the addition
of antibiotics for 5 days. Eight microbial media were used
for the detection of bacteria and fungi, including thiogly-
collate medium (Difco 0256-01), Sabouraud dextrose
broth (Difco 0382-01), Trypticase soy broth (BBL 01-
162), Brain heart infusion (BHI) broth (Difco 0037-01-
6), YM broth (Difco 0711-01), Blood agar plates (with
fresh defibrinated rabbit blood) (Difco 0045-01), Nutri-
ent broth incline planes (Difco 003-01) and Martin mod-
ified medium. Of the eight media employed, trypticase
soy, BHI, blood agar and thioglycollate were used to
detect a wide range of bacterial contaminants. Sabouraud
broth, YM broth, nutrient broth incline planes and Martin
modified medium were used to detect fungal contami-
nants. The test regimen was listed in Table 2. 1 ml of the
5-day cultured supernatant was added into each medium,
and incubated at different temperatures for 14 and 21
days. Each medium at each temperature was tested in trip-
licate.
Testing for Mycoplasma
The cell lines were examined for mycoplasma using both
direct and indirect assays [17]. In the direct assays, myco-
plasma growth agar plates were prepared with myco-
plasma agar base (Becton-Dickinson 11456) and horse
serum (GIBCO). 1.0 ml of the 5-day cultured supernatant
was inoculated onto the mycoplasma growth agar plates
and incubated anaerobically at 37°C. Vero (CCTCC
GDC0029) and B6yH4 (CCTCC GDC0017) cells
obtained from CCTCC were used as negative and positive
control respectively. Typical mycoplasma colonies were
microscopically examined very week for at least 3 weeks.
In the indirect assay, mycoplasma DNA was examined by
staining the cells with Hoechst 33258. Vero cell line was
used as the indicator cell in the DNA staining procedure.
Vero cells were inoculated on a cover slip in 12-well
microplates with 1.0 × 105 cells/well. After 24 hours, 0.2
ml to 0.5 ml of each test cell line were added to the wells
of Vero cells, 2 wells/cell line. 0.5 ml supernatant of
B6yH4 cells was added to 2 wells as positive control and
1.0 ml culture medium was added to 2 wells as negative
control. The 12-well microplates were incubated at 37°C
in a humidified incubator containing 5% carbon dioxide.
After 6 days, cells were washed with PBS twice, fixed with
fixative (methanol: acetic acid = 3:1) for 15 minutes twice
and stained with Hoechst 33258 in the dark for 45 min-
utes. The cover slips were then washed with distilled water
three times, dried in the dark at room temperature, placed
in a drop of mounting medium (10% glycerin in PBS) on
glass slides, and observed under fluorescence microscope
with 330–380 nm excitation filter. Extracellular fluores-
cence indicated mycolpasma contamination.
Isoenzyme Analysis
To verify that the three breast cancer cell lines were
derived from humans without cross-contamination, we
compared the profiles of lactate dehydrogenase (LD) and
malate dehydrogenase (MD) from the 3 breast cancer cell
lines. HeLa cell line and mouse fibroblast L929 cell line
were used as standard references. LD and MD were ana-
lyzed using AuthentiKit™ (Innovative Chemistry Marsh-
field, MA) following the manufacturer instructions.
Immunocytochemistry Analysis
ER, PR and C-erbB-2 had been used as marker for the
detection of breast cancer in clinical diagnosis [18-21].
The expression of ER, PR and C-erbB-2 were detected by
using SuperRmEPC™ Breast Cancer detection Kit from
Maxim Biotechnology Development Co., Ltd MRC-5 cell
Table 2: Regimen for detecting bacterial and fugal contamination
Test medium Temperature (°C) Gas phase Observation time (days)





Brain heart infusion broth 37
26
Aerobic 14












Nutrient broth incline planes 37
26
Aerobic 21
Martin modified medium 37
26
Aerobic 21Cancer Cell International 2009, 9:2 http://www.cancerci.com/content/9/1/2
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line (ATCC CCL-171) and MCF-7 cell line (ATCC HTB-
22) were used as negative control and positive control,
respectively.
Assay of Tumorigenicity in Nude Mice in vivo
Large-scale cultures were prepared at P21 for BC-019, P22
for BC-020 and P20 for BC-021. Cells were washed twice
with MEM without serum and antibiotics and adjusted to
5~10 × 107 cells/ml in PBS. The same procedure was done
to MRC-5 cell line and MCF-7 cell line, the negative and
positive controls. MRC-5 and MCF-7 were cultured in
MEM supplemented with 10% fetal bovine serum, peni-
cillin (100 U/mL), and streptomycin (100 μg/mL). 10 μg/
mL bovine insulin was added to the medium for MCF-7.
4 weeks old nude mice were injected subcutaneously with
0.2 ml cell suspension at left groin. Each cell line was used
to inject 10 mice. All the mice were examined within 8
weeks [22-24].
Chromosomal Analysis
BC-019, BC-020 and BC-021 cells at passage 23 were used
for chromosome analysis. Metaphase cells were collected
after 3-hour colcemid (0.2 μg/mL) exposure and incuba-
tion in 0.075 M KCl solution at 37°C for 40 min. After fix-
ing with a mixture of methanol and glacial acetic acid
(3:1, v/v), cell suspensions were spread onto cold slides.
The slides were stained with 3% Giemsa for morphologi-
cal examination and chromosomes analysis [25]. G-band-
ing of the chromosomes was obtained by carried out by
standard trypsin-Giemsa banding technique[26,27].
Results
Establishment of Cell Lines
The epithelial cells grew gradually from explants in all the
25-cm2 culture flasks and formed sparse colonies within 5
days of primary culture. The first successful subculture of
3 cell lines was performed on about 14th day and the sec-
ond one 3 days later. 5 passages later, cells were subcul-
tured at a split ratio of 1:3 every 3–4 days. The breast
cancer cells grew as adherent monolayer with characteris-
tic epithelial morphological features (Fig. 1). The breast
cancer cells have grown continuously for over 6 months
after initiation and have undergone more than 45 pas-
sages (BC-019: 51 passages; BC-020: 46 passages; BC-021:
48 passages). After thawing from liquid nitrogen, the cry-
opreserved cells could be propagated in culture without
noticeable change in growth and morphology.
Growth Characteristics of Cell Lines
The growth kinetics of BC-019, BC-020 and BC-021 cells
at passage 21 were studied. The growth curves of these cell
lines were shown in Fig. 2. The population-doubling time
of BC-019, BC-020 and BC-021 were 36 hours, 35 hours
and 46 hours, respectively.
Contamination Tests
These test regimens could detect most common bacterial,
fungal organisms and mycoplasma in cell cultures. We did
not detect bacterial and fungal contaminants in the three
breast cancer cell lines by using eight growth media. Myc-
oplasma agar culture and Hoechst 33258 fluorescence
staining indicated that there was no mycoplasma in the
three new breast cancer cell lines (Fig. 3). Altogether, con-
tamination tests indicated that the three breast cancer cell
lines were free of bacterial and fungal agents as well as
mycoplasma.
Isoenzyme Analysis
We compared the profiles of lactate dehydrogenase and
malate dehydrogenase from the three breast cancer cell
lines together with HeLa cells and mouse fibroblast L929
cells. The results were shown in Fig. 4. The profiles of the
two dehydrogenases from these breast cancer cell lines
were identical to those from HeLa cells, but distinct from
Morphology of three breast cancer cell lines Figure 1
Morphology of three breast cancer cell lines. A: BC-019 cell line at passage 21 (×100); B: BC-020 cell line at passage 22 
(×100); C: BC-021 cells at passage 20 (×100).Cancer Cell International 2009, 9:2 http://www.cancerci.com/content/9/1/2
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those of mouse fibroblast cell line L929. These data
showed that the origin of these three cell lines was human
tissue.
The Expression of ER, PR and C-erbB-2 MarKers
The expression of ER, PR and C-erbB-2 in three breast can-
cer cell lines was detected by using the SuperRmEPC™
Breast Cancer detection Kit. As shown in Fig. 5, all the
three new breast cancer cell lines were positive for ER, PR
and C-erbB-2 and there were no notable difference at the
expression level among the three breast cancer cell lines.
Compared with MCF-7, the expression level of ER and PR
in breast cancer cell lines was higher than that of MCF-7
and the expression of C-erbB-2 was similar with that of
MCF-7. On the other hand, the negative control cell line
MRC-5 did not appear to express ER, PR and C-erbB-2.
Altogether, the data of immunocytochemistry analysis
provided the evidence that the three newly established
cancer cell lines are from human breast malignancy.
Growth curves of 3 breast cancer cell lines Figure 2
Growth curves of 3 breast cancer cell lines. The cells seeded at 2 × 103 cells per well and measured by MTT every 24 h. 
The growth curves were plotted with the cells numbers within 7 days.
Mycoplasma detection of breast cancer cell lines Figure 3
Mycoplasma detection of breast cancer cell lines. Mycoplasma colonies were seen as fried-egg morphology at the posi-
tive control agar plates Mycoplasma contamination was seen as the numerous small extracellular fluorescing particles by 
Hoechst 33258 fluorescence staining.Cancer Cell International 2009, 9:2 http://www.cancerci.com/content/9/1/2
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Highly Tumorigenicity of Three Cell Lines in Nude Mice
To further investigate the in vivo tumorigenicity of these
new breast cancer cell lines, the xenograft transplanation
to nude mice was performed. Within 10–14 days after
subcutaneous injection of breast cancer cells, visible sub-
cutaneous tumors were developed in all of the 30 nude
mice at the site of inoculation while the tumors in MCF-
7-injected nude mice appeared within 20 days post-injec-
tion. The dimension of these tumors ranged from 1.5 to
2.0 cm within 5 weeks post-injection (Fig. 6). At the same
time, the negative control cell line MRC-5 did not exhibit
tumorigenicity in 10 nude mice (Fig. 6E). Furthermore,
tumor metastasis occurred occasionally in the nude mice
injected with BC-019 cells (1/10) and BC-021 cells (1/
10)(Fig. 6-A, C). Tumors appeared on both sides of the
groins, while the cells were only injected into the left
groin. No metastasis was found in the nude mice injected
with either BC-020 cells or MCF-7 cells. This result indi-
cated that the newly established breast cancer cell lines
were highly tumorigenic in vivo.
Chromosome Analysis
Karyotype analyses were carried out to determine the
modal number of chromosomes by standard Giemsa
staining. 1000 cells of each cell line were counted and
chromosome numbers in BC-019, BC-020 and BC-021
cells were ranged between 35 to 67, 40 to 70 and 38 to 65
with median ranges 53–56, 53–56 and 60–64 respectively
(Fig. 7). In all the three cell lines, the karyotypes were
mostly multiploid and many chromosomal abnormalities
were observed. Many chromosomes were fractured at the
centromeres and most of the fractured chromosomes
could not be identified. The chromosomal abnormalities
were much more severe in BC-021 cell line.
Discussion
Well-characterized human cancer cell lines are important
resources for studying cancer cell biology, as well as for
developing new strategies against cancer cell growth and
progression[28]. In this study, we reported the establish-
ment and characterization of three new breast cancer cell
lines, BC-019, BC-020 and BC-021, which were derived
from breast invasive ductal carcinoma tissues of Chinese
female patients.
The newly established cells grew as adherent monolayer
with characteristic epithelial morphology. The cultured
cells maintained consistent morphology from the primary
culture to the subsequent subculture passages. These cells
have grown continuously for over 6 months and have
undergone more than 45 passages. They appeared to be
permanent cell lines since growth continued after recovery
from cryopreservation. The population-doubling time of
BC-019, BC-020 and BC-021 were 36 hours, 35 hours and
46 hours, respectively.
We did not add any insulin to the medium in primary cul-
ture to maintain the cell lines, while it was necessary for
most of routinely used breast cancer cell lines, such as
MCF-7, T-47D, MDA-MB-435S and so on[4,7,29]. We
found that the absence of insulin in the culture medium
did not affect the characteristics of these three cell lines.
Therefore, it is more convenient to culture these cell lines.
The contaminations would do great harm to cell cultures.
In our contamination tests, no bacteria and fungi or myc-
oplasma could be found in the three cell lines. Isoenzyme
analysis was used to verify the origin of species. We ana-
lyzed the lactate dehydrogenase and malate dehydroge-
nase of the new cell lines. The results indicated that the
origin of the three cell lines was identical to HeLa cell line.
So the three breast cancer cell lines were derived from
human tissues and there were no other species cross-con-
tamination during the proliferation. Meanwhile, all the
three cell lines were positive for the expression of estrogen
receptor, progesterone receptor and C-erbB-2. This result
Isoenzymology analysis of lactate dehydrogenase (LD) and  malate dehydrogenase (MD) in the three breast cancer cell  lines Figure 4
Isoenzymology analysis of lactate dehydrogenase 
(LD) and malate dehydrogenase (MD) in the three 
breast cancer cell lines. HeLa is human control and L929 
is mouse control. The bands of breast cancer cells were 
identical to those from HeLa but distinct from L929, indicat-
ing that the breast cancer cells had the same origin as of 
HeLa cells.Cancer Cell International 2009, 9:2 http://www.cancerci.com/content/9/1/2
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Immunocytochemical analysis of three breast cancer cell lines Figure 5
Immunocytochemical analysis of three breast cancer cell lines. The expression of ER, PR and C-erbB-2 were detected 
by using SuperRmEPC™ Breast Cancer detection Kit, all the three cell lines were positive for the three markers, in immunocy-
tochemistry anslysis.Cancer Cell International 2009, 9:2 http://www.cancerci.com/content/9/1/2
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Tumorigenicity test of breast cancer cells in nude mice Figure 6
Tumorigenicity test of breast cancer cells in nude mice. Red arrows indicated the tumors in the nude mice. A: One 
nude mice 30 days post-injection of BC-019 cells, where tumors appeared on both groins; B: One nude mice 30 days post-
injection of BC-020 cells; C: One nude mice 30 days post-injection of BC-021 cells, where tumors appeared on both groins; D: 
One nude mice 30 days post-injection of MCF-7 cells (positive control); E: One nude mice 30 days post-injection of MRC-5 
cells (negative control).
Distribution of chromosome numbers in three breast cancer cell lines Figure 7
Distribution of chromosome numbers in three breast cancer cell lines.Cancer Cell International 2009, 9:2 http://www.cancerci.com/content/9/1/2
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demonstrated clearly that the three cell lines were derived
from human breast cancer tissues.
The karyotypes of the three breast cancer cell lines showed
chromosomes with hyperdiploidy and complex rear-
rangements. The pronounced heterogeneity suggested
that these three cell lines consisted of karyotypically dif-
ferent clones. The main heterogeneity of the three cell
lines was chromosome fracture at the centromeres and
most of the fractured chromosomes could not be identi-
fied. The fractured chromosomes were in larger number in
BC-021 than in the other two cell lines. The hyperdiploidy
(> 50 chromosomes) may arise from fracture of the chro-
mosomes.
The three breast cancer cell lines had been proved to have
severe tumorigenicity when injected into nude mice, and
their tumorigenicity was higher than that of MCF-7 cell
line. Metastasis could be occasionally observed in nude
mice injected with BC-019 cells and BC-021 cells, but not
in mice injected with BC-020 cells and MCF-7 cells. It was
well known that breast cancer cell lines tend to be less
tumorigenic and less metastatic than other cell lines
derived from lung, renal and colon carcinoma when
injected subcutaneously in nude mice[30]. Interestingly,
these three cell lines could form tumors at 100% rate
when injected in nude mice within two weeks, and the
maximum dimension of these tumors reached 2.0 cm
within 5 weeks post-injection. The size of the tumor was
bigger than that formed by MCF-7 under same conditions.
It seems that these newly established breast cancer cell
lines could be new in vivo models for studying the biology
of breast cancer.
Most of the previously established breast cancer cell lines
used in research did not derive from primary breast
tumors, but from tumor metastases, especially ascites or
pleural effusions. While primary cultures are indispensa-
ble for direct comparison to the tissue of origin, immor-
talized cell lines are necessary for long-term studies
[31,32]. Therefore, these new cell lines will be valuable
tools in breast cancer research. Not only are cells directly
isolated from the tumor site, but also detailed pathology
is available to allow the characteristics of the culture to be
compared with those of the original tumor.
Moreover, most of the published breast cancer cell lines
were derived from Caucasians, which limited the study of
pathogenic mechanism of breast cancer among Asian
patients. To resolve this problem, we established three
breast cancer cell lines which were derived from Chinese
and provided a research resource and tool to compare the
difference of cells and tumors between the two races.
Conclusion
We established and characterized three new human breast
cancer cell lines designating BC-019, BC-020 and BC-021
from three Chinese patients. These three cell lines would
provide us new experimental models to study the patho-
genic mechanism, to investigate the biological behavior
and to test new therapeutic reagents for breast cancer.
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